6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

108 trials found

diseases per page:

Showing 1 to 10 of 108 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05611372 (ClinicalTrials.gov)	January 1, 2023	6/11/2022	Efficacy and Safety of Rasagiline in Prodromal Parkinson's Disease	Efficacy and Safety of Rasagiline in Prodromal Parkinson's Disease	REM Sleep Behavior Disorder;Parkinson Disease;Synucleinopathies	Drug: Rasagiline	Second Affiliated Hospital, School of Medicine, Zhejiang University	Beijing Tiantan Hospital;Xinhua Hospital, Shanghai Jiao Tong University School of Medicine;Jiangsu P ...	Not yet recruiting	30 Years	75 Years	All	732	Phase 2/Phase 3	NULL
2	JPRN-JapicCTI-184181	01/11/2018	30/10/2018	Rasagiline Tablets Special Drug Use-Results Survey Survey on Long-term Safety	AZILECT Tablets Special Drug Use-Results Survey Survey on Long-term Safety	Parkinson's disease	Intervention name : Rasagiline INN of the intervention : rasagiline Dosage And administration of the i ...	TAKEDA PHARMACEUTICAL COMPANY LTD.	NULL	complete			BOTH	1021	NA	Japan
3	NCT03727139 (ClinicalTrials.gov)	November 1, 2018	30/10/2018	Rasagiline Tablets Special Drug Use-Results Survey Survey on Long-term Safety	AZILECT Tablets Special Drug Use-Results Survey Survey on Long-term Safety	Parkinson's Disease	Drug: Rasagiline	Takeda	NULL	Completed	N/A	N/A	All	1021		Japan
4	ChiCTR1800016949	2018-08-01	2018-07-04	Efficacy assessment and standard treatment of rasagilinein Chinese patients with early Parkinson's d ...	Efficacy assessment and standard treatment of rasagilinein Chinese patients with early Parkinson's d ...	Parkinson's disease	Rasagiline early start group:rasagiline-rasagiline;Rasagiline delay start group:placebo-rasagiline;	Beijing Hospital	NULL	Pending	30	80	Both	Rasagiline early start group:130;Rasagiline delay start group:130;		China
5	EUCTR2017-001420-21-DE (EUCTR)	18/06/2018	16/02/2018	Clinical Efficacy, Safety and Tolerability of P2B001 in Early Parkinson's Disease	A Phase 3, Twelve-week, Multi-Center, Multinational, Randomized, Double-Blind, Double-Dummy, Paralle ...	Early Parkinson's Disease MedDRA version: 20.0;Level: HLT;Classification code 10034005;Term: Parkins ...	Product Code: P2B001 INN or Proposed INN: PRAMIPEXOLE DIHYDROCHLORIDE Other descriptive name: PRAMIPEXO ...	Pharma Two B Ltd	NULL	Not Recruiting			Female: yes Male: yes	525	Phase 3	France;United States;Canada;Spain;Germany
6	EUCTR2017-001420-21-ES (EUCTR)	13/06/2018	15/03/2018	Clinical Efficacy, Safety and Tolerability of P2B001 in Early Parkinson's Disease	A Phase 3, Twelve-week, Multi-Center, Multinational, Randomized, Double-Blind, Double-Dummy, Paralle ...	Early Parkinson's Disease MedDRA version: 20.0;Level: HLT;Classification code 10034005;Term: Parkins ...	Product Code: P2B001 INN or Proposed INN: PRAMIPEXOLE DIHYDROCHLORIDE Other descriptive name: PRAMIPEXO ...	Pharma Two B Ltd	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	525	Phase 3	United States;France;Canada;Spain;Germany
7	NCT03843944 (ClinicalTrials.gov)	May 1, 2018	12/2/2019	Overnight Switch From Rasagiline To Safinamide	Overnight Switch From RasagilineTo Safinamide In Fluctuating Patients With Parkinson's Disease: A To ...	Parkinson Disease	Drug: Safinamide	IRCCS San Raffaele Roma	NULL	Completed	30 Years	80 Years	All	20	Phase 4	Italy
8	NCT03648671 (ClinicalTrials.gov)	March 28, 2018	26/6/2018	Pain in Parkinson's Disease With Motor Fluctuations.	Spontaneous and Evoked Pain in Parkinson's Disease With Motor Fluctuations: an Observational, Prospe ...	Parkinson Disease	Drug: safinamide metansolfonato (12 weeks);Drug: rasagilina mesilato (12 weeks)	Universita di Verona	Azienda Ospedaliera Universitaria Integrata Verona	Unknown status	18 Years	80 Years	All	48		Italy
9	NCT03329508 (ClinicalTrials.gov)	January 29, 2018	30/10/2017	A Phase 3 Study With P2B001 in Subjects With Early Parkinson's	A Phase 3, Twelve-week Study to Determine the Efficacy, Safety and Tolerability of P2B001 Once Daily ...	Parkinson Disease;Early Parkinson's Disease	Drug: P2B001;Drug: Rasagiline;Drug: Pramipexole;Drug: Pramipexole ER	Pharma Two B Ltd.	NULL	Active, not recruiting	35 Years	80 Years	All	525	Phase 3	United States;Canada;Germany;Spain
10	NCT02789020 (ClinicalTrials.gov)	December 2016	20/5/2016	Image Parkinson's Disease Progression Study	Image Parkinson's Disease Progression Study	Parkinson's Disease	Drug: Rasagiline;Other: Placebo;Device: Magnetic Resonance Imaging;Device: functional Magnetic Reson ...	University of Florida	National Institute of Neurological Disorders and Stroke (NINDS)	Active, not recruiting	40 Years	77 Years	All	96	Phase 2	United States

First Previous1 2 3 4 5…11Next Last